Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PoC study results support efficacy of lonafarnib in patients with HDV

March 10, 2015

Pharmacokinetics of topical umeclidinium for hyperhidrosis determined

March 10, 2015

Studies advance darunavir/cobicistat/emtricitabine/tenofovir alafenamide single tablet formulation

March 9, 2015

EMD Serono presents data from phase I study of MSC-2363318A

March 9, 2015

Bacteriolytic therapy feasible in advanced sarcoma patients

March 9, 2015

Ferritin and IL-8 associated with clear cell renal carcinoma outcome

March 9, 2015

Urine-based prostate cancer diagnostic may help avoid unnecessary biopsies

March 9, 2015

Novel DNA-based therapy shows efficacy for advanced ovarian cancer treatment

March 6, 2015

[68Ga]PSMA PET/CT shows promise for detecting prostate cancer recurrence

March 6, 2015

EC-1169 drug conjugate is safe in mCRPC patients

March 6, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...